Immediate Impact
2 from Science/Nature 53 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Works of Kerry A. Rogers being referenced
Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia
2020
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kerry A. Rogers | 1088 | 857 | 396 | 408 | 121 | 1.3k | |
| Loïc Ysebaert | 892 | 762 | 436 | 424 | 57 | 1.3k | |
| Florence Cymbalista | 1232 | 934 | 489 | 449 | 81 | 1.7k | |
| Deborah M. Stephens | 1003 | 1053 | 332 | 346 | 137 | 1.6k | |
| Seema A. Bhat | 612 | 530 | 223 | 222 | 67 | 1.3k | |
| Gerardo Musuraca | 509 | 1193 | 337 | 190 | 81 | 1.6k | |
| Rémi Letestu | 667 | 527 | 374 | 394 | 52 | 1.1k | |
| Carlos Panizo | 385 | 518 | 266 | 281 | 91 | 1.4k | |
| Karim Maloum | 1195 | 907 | 611 | 322 | 50 | 1.6k | |
| Francesco Cavazzini | 696 | 454 | 389 | 382 | 66 | 1.3k | |
| Judit Demeter | 543 | 535 | 262 | 415 | 107 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...